Canadian Pancreatic Cancer Specialist Expects to Open Clinical Trials on Pill That Doubled Survival Time

A doctor wears a lab coat and stethoscope at a health clinic in Calgary on July 14, 2023. The Canadian Press/Jeff McIntosh

The head of pancreatic cancer at Princess Margaret Cancer Centre says she hopes clinical trials for a pill that could double survival time will soon be open to Canadian patients.

Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results “amazing.”